Oaktree Acquisition Corp. III Life Sciences(OACC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
OACC Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Oaktree Acquisition Corp. III Life Sciences (OACC), a Financials sector company. OACC is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of OACC by reported 13-F value include AQR Arbitrage, Fort Baker Capital Management, Decagon Asset Management LLP, based on the most recent SEC filings. OACC trades on the Nasdaq exchange and files with the SEC under CIK 2029769. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OACC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Oaktree Acquisition Corp. III Life Sciences directly from SEC EDGAR.
Net Income
Q2 2026
$1.6M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
Operating Income
Total Assets
+4.0% YoYOp. Cash Flow
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Net Income | $7.3M | — |
| Operating Income | $-1.2M | — |
| Total Assets | $203.1M +4.0% | $195.3M |
| Operating Cash Flow | $-422.1K | — |
Get alerted when OACC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Oaktree Acquisition Corp. III Life Sciences including:
Top Institutional Holders of OACC
AQR Arbitrage LLC
$14.2M1,324,175 shFort Baker Capital Management LP
$11.8M1,105,394 shDecagon Asset Management LLP
$11.7M1,091,327 shEmpyrean Capital Partners, LP
$9.6M900,000 shD. E. Shaw & Co., Inc.
$9.2M861,625 shBOUSSARD & GAVAUDAN GESTION SAS
$7.7M720,000 shLINDEN ADVISORS LP
$6.4M600,000 shTORONTO DOMINION BANK
$5.9M554,294 shSculptor Capital LP
$5.7M530,807 shGOLDMAN SACHS GROUP INC
$5.7M529,535 sh
| Fund | Value | Shares |
|---|---|---|
| AQR Arbitrage LLC | $14.2M | 1,324,175 |
| Fort Baker Capital Management LP | $11.8M | 1,105,394 |
| Decagon Asset Management LLP | $11.7M | 1,091,327 |
| Empyrean Capital Partners, LP | $9.6M | 900,000 |
| D. E. Shaw & Co., Inc. | $9.2M | 861,625 |
| BOUSSARD & GAVAUDAN GESTION SAS | $7.7M | 720,000 |
| LINDEN ADVISORS LP | $6.4M | 600,000 |
| TORONTO DOMINION BANK | $5.9M | 554,294 |
| Sculptor Capital LP | $5.7M | 530,807 |
| GOLDMAN SACHS GROUP INC | $5.7M | 529,535 |
More Financials Companies
View all Financials →Put OACC on your watchlist
Track score changes the day Oaktree Acquisition Corp. III Life Sciences files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OACC a good stock to buy?
13F Pro's AI-powered analysis of Oaktree Acquisition Corp. III Life Sciences (OACC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OACC are available on the OACC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. OACC is classified as a small company.
Which hedge funds own OACC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OACC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Oaktree Acquisition Corp. III Life Sciences's investment landscape.